Barley Beta-Glucan May Lower Glucose Spikes—But Does It Last Until Lunch?

Barley beta-glucan can reliably soften the glucose and insulin rise after a meal. The best current synthesis found lower post-meal blood glucose by 10.48 mg/dL at 30 minutes, 12.38 mg/dL at 60 minutes, and 6.95 mg/dL at 120 minutes. That is useful, measurable physiology—not a promise to rewrite your HbA1c.

The more intriguing question is whether barley at dinner can improve glucose handling the next morning. A small trial raises that possibility and points to the gut microbiota as the messenger. The biology makes sense, but the direct evidence does not yet establish that beta-glucan fermentation causes a second-meal benefit in healthy people.

What 31 controlled trials actually show

A 2026 systematic review and meta-analysis by Nematizadeh et al. combined 34 intervention arms from 31 controlled trials, totaling 1,325 adults. Barley interventions significantly reduced postprandial glucose at 30, 60, and 120 minutes. The glucose difference was no longer significant at 180 minutes.

Insulin followed a less tidy curve: levels fell significantly by 6.02 pmol/L at 30 minutes, 12.83 pmol/L at 60 minutes, and 5.89 pmol/L at 180 minutes, but not significantly at 120 minutes. Those results describe an acute change in how the body handles a meal. They do not show a durable metabolic reset.

Across the same trials, barley did not significantly improve fasting glucose or HbA1c. That matters for anyone tempted to turn a favorable continuous-glucose-monitor trace into a claim about long-term diabetes prevention. A lower post-meal peak can be worthwhile, especially when a meal is carbohydrate-heavy, but it is a surrogate outcome. The meta-analysis did not find evidence that the intervention changed longer-term average glycemia.

Viscosity is the established mechanism

Beta-glucan is a soluble fiber. When enough of it remains high in molecular weight, it thickens the contents of the small intestine and slows glucose movement toward the intestinal surface where absorption occurs. Think less "microbiome wizardry" and more "traffic-calming gel." The result is a flatter absorption curve.

Direct evidence for this physical explanation comes from a 2022 human intervention study by Ballance et al. in healthy adults with overweight. After simulated digestion, the solution properties of galactomannan in guar-fortified bread quantitatively predicted the degree of postprandial insulin reduction. This was not a beta-glucan trial, but it supports the broader principle: the physical behavior of high-molecular-weight soluble polysaccharides predicts their acute glycemic effect.

Processing can weaken that behavior. A 2021 review of grain processing found that heat, mechanical treatment, fermentation, baking, and extrusion can alter both the amount and structural characteristics of cereal fiber. Molecular-weight degradation can reduce viscosity. A package that lists dietary fiber tells you how much fiber is present; it does not tell you whether the beta-glucan still has the molecular structure that produces much viscosity in the gut.

The case for a next-meal effect

The second-meal effect is real: the composition of one meal can affect glucose or insulin responses to the meal that follows. What remains unsettled is which mechanisms drive it in any given food.

A 2023 randomized crossover study by Telle-Hansen et al. tested this question with granola in healthy adults. Twenty people enrolled and 14 completed the three-day intervention. Participants ate an evening granola containing approximately 1.5 g, 3.2 g, or 6.6 g of beta-glucan, then underwent an oral glucose tolerance test the next morning. The medium-beta-glucan product was associated with the strongest improvement in next-morning glycemic response, alongside changes in the relative abundance of several bacterial groups, including Haemophilus, Veillonella, and Sutterella.

That result is interesting because beta-glucan that reaches the colon can be fermented by microbes into short-chain fatty acids, or SCFAs. SCFAs can stimulate gut hormones such as GLP-1 and PYY, which could influence insulin sensitivity or appetite at a later meal. But the study did not measure fecal or plasma SCFAs, GLP-1, or PYY. It found a next-morning glycemic difference and microbiota changes; it did not prove that one caused the other.

There is human evidence for a related fermentation-to-second-meal pathway. In a 2023 randomized crossover trial by Costabile et al., high-amylose wheat bread at breakfast increased plasma propionate and reduced the postprandial insulin response to a subsequent meal in adults with overweight. This is a persuasive proof of concept for a grain food affecting the next meal through colonic fermentation. Yet it used resistant starch, measured propionate, and assessed insulin—not beta-glucan, not a beta-glucan-specific SCFA profile, and not the same population or intervention.

A 2024 randomized crossover pilot study by Steinert et al. adds another link in the chain. In people who had undergone Roux-en-Y gastric bypass surgery, inulin supplementation supported the idea that colonic SCFA production can stimulate GLP-1 and PYY and alter postprandial glycemia. Gastric-bypass anatomy and microbiota differ substantially from those of healthy adults, so this study supports biological plausibility rather than confirming the barley hypothesis.

Why the microbiota explanation remains a hypothesis

The granola trial was too small and too short to settle a microbiota mechanism. Fourteen completers cannot provide stable taxonomic conclusions, and three days can capture acute modulation without showing durable remodeling of the microbiome.

More importantly, beta-glucan was not the only variable. All granolas contained inulin, as well as arabinoxylan from rye and wheat and cellulose. Inulin content ranged from about 7.6 g per 100 g in the low-beta-glucan product to about 4.1 g per 100 g in the high-beta-glucan product. Total dietary fiber ranged from about 16.3 to 22.0 g per 100 g. The products therefore differed in their overall fermentable-fiber mix, not simply in beta-glucan dose.

The high-dose product also used Betavivo, an extruded oat product with high molecular weight and a physical form distinct from the rolled oat and barley granola used in the medium-dose arm. Physical form, molecular weight, viscosity, starch accessibility, and fermentation can all affect glycemic responses. The finding that the medium-dose product performed best does not establish that 3.2 g is better than 6.6 g of beta-glucan.

There is also a credible non-fermentation explanation. A 2024 randomized crossover trial by Peng et al. found that fresh-cooked millet produced a significant second-meal effect independent of resistant starch. The investigators proposed slowly digestible starch and altered gastric emptying as explanations. In other words, a grain can influence the next meal without relying on colonic fermentation. That possibility fits the multi-ingredient granola study at least as well as a microbiota relay does.

Research on beta-glucan and microbiota composition remains thin. A 2024 in vitro study by Asensio-Grau et al. tested beta-glucan with fecal microbiota from people with cystic fibrosis. It cannot confirm what beta-glucan does in the microbiota of healthy adults.

How to use barley without overselling it

Use barley beta-glucan for the effect supported by the strongest evidence: reducing the glucose and insulin rise after a meal. High-molecular-weight, minimally processed barley or oat foods are the most sensible choices because viscosity appears to drive the acute effect. A practical target is roughly 3 to 4 g of beta-glucan with the meal most likely to produce a large glucose rise.

• Choose minimally processed barley, barley flakes, or intact oat products when practical.
• Use beta-glucan with a carbohydrate-rich meal, where slowing absorption has the most obvious target.
• Do not treat a fiber label as proof of molecular weight or glycemic potency.
• Consider any next-morning benefit a possible bonus, not a feature you can count on.

Barley beta-glucan has a well-supported acute effect on post-meal glucose. The proposed microbiota-mediated effect at the next meal is biologically credible, but a dedicated, adequately powered trial must measure beta-glucan exposure, SCFAs, gut hormones, and next-meal glucose before it becomes established advice.

The science leaves room for curiosity, not certainty. Eat barley because the immediate effect is replicated. Wait for better trials before crediting your lunch glucose to microbes that may—or may not—have received breakfast's memo.